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Fever Syndromes in Low-
Resource Settings
To THE EDITOR—We read with interest
the editorial commentary by Crump [1],
which emphasizes the need for a syn-
dromic approach to fever in low-resource
settings—citing 2 recent epidemics of Sal-
monella Typhi [2, 3], the decreasing pro-
portion of malaria-attributable illness in
many areas, and changing vaccination
patterns as arguments. We strongly agree
with this point and wish to emphasize
the role of microbiologic diagnostic tests
in this process.
Although the beneﬁts of parasitologi-
cal diagnosis of malaria are widely em-
phasized [4], using malaria diagnosis
alone as the cornerstone of linking
febrile patients to appropriate care is
dangerous. For example, the Institute of
Tropical Medicine, Antwerp, was recent-
ly asked for assistance by colleagues in
the remote Bwamanda health zone of
the Democratic Republic of the Congo,
which was facing an outbreak of severe
malarial anemia in the second half of
2011. A dramatic increase in blood
transfusion requirements and in-hospital
mortality was observed among children
<5 years of age with parasitologically
conﬁrmed malaria. Intensiﬁed surveil-
lance of bloodstream infections in De-
cember 2011 via the national reference
laboratory in Kinshasa recovered 57
nontyphoidal Salmonella isolates among
135 blood cultures in severely ill chil-
dren (42%). This large unrecognized
outbreak of severe disease from a clonal
strain of Salmonella illustrates the pitfalls
of focusing on a single pathogen, such
as malaria, in patients presenting with
febrile illnesses in low-resource settings.
Further, widespread adoption of
malaria rapid diagnostic tests (RDT) has
resulted in dramatic increases in empiric
antibacterial use among the three-quar-
ters of febrile patients in whom no
malaria is found [5]. This dichotomous
diagnostic approach can only fuel
emerging antimicrobial resistance in the
settings that can least afford it [6].
Choosing rational empiric therapy for
patients with febrile syndromes in low-
resource settings is complicated by the
fact that a large proportion of them may
be caused by any of several geographi-
cally restricted infections and neglected
tropical diseases, such as tick-borne bor-
reliosis [7], visceral leishmaniasis [8],
and human African trypanosomiasis.
Such infections are severe and treatable
but often clinically indistinguishable
without conﬁrmatory tests. Making
matters worse, very little epidemiologic
data underpin clinicians’ assessment of
prior probability in vast areas of Africa
and Asia.
A syndromic approach to patients with
fever that integrates relevant combina-
tions of RDT is urgently needed in many
parts of the world. This will require (1)
comprehensive epidemiologic studies
using reference standard techniques to
determine the prevalence of priority dis-
eases that are severe and treatable; (2)
validation of existing RDT in ﬁeld set-
tings and development of new RDT for
key pathogens of epidemiologic impor-
tance; and (3) evidence-based algorithms
incorporating local epidemiological data
and setting-speciﬁc RDT diagnostic con-
tributions, because the latter can vary
substantially by locality [9, 10].
We are working as part of the EU-
funded NIDIAG (Neglected Infectious
Disease dIAGnosis) consortium to
develop such an approach to persistent
fever in 4 low-resource countries, with
the aim of achieving patient-centered
care pathways that will accelerate diag-
nosis and improve outcomes.
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